Clinical Trials
20
Active:0
Completed:3
Trial Phases
4 Phases
Phase 1:2
Phase 2:1
Phase 4:1
+1 more phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Not Applicable
6 (60.0%)Phase 1
2 (20.0%)Phase 2
1 (10.0%)Phase 4
1 (10.0%)Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
- First Posted Date
- 2024-09-05
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Beijing Neurosurgical Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06585527
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, Beijing, China
Clinical Study on the Safety and Efficacy of Novel Oncolytic Virus in the Treatment of Recurrent Malignant Glioma
Phase 1
Completed
- Conditions
- Glioblastoma MultiformeGliomas, Malignant
- Interventions
- Biological: ON-01Drug: ONF
- First Posted Date
- 2024-08-20
- Last Posted Date
- 2024-08-20
- Lead Sponsor
- Beijing Neurosurgical Institute
- Target Recruit Count
- 38
- Registration Number
- NCT06562621
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, Beijing, China
Accelerating Motor Recovering in Patients With SMA Syndrome After Glioma Surgery by Using nrTMS
Not Applicable
Recruiting
- Conditions
- Supplementary Motor Area SyndromeMotor Cortex; LesionGlioma
- First Posted Date
- 2023-04-07
- Last Posted Date
- 2023-05-03
- Lead Sponsor
- Beijing Neurosurgical Institute
- Target Recruit Count
- 64
- Registration Number
- NCT05803057
- Locations
- 🇨🇳
Beijing Neurosurgical Institute and Beijing Tiantan Hospital, Beijing, Beijing, China
High-frequency nrTMS on the Contralateral Broca Mirror Area for Glioma Patients With Early Postoperative Aphasia
Not Applicable
Not yet recruiting
- Conditions
- GliomaNon-fluent Aphasia
- First Posted Date
- 2023-03-28
- Last Posted Date
- 2023-03-28
- Lead Sponsor
- Beijing Neurosurgical Institute
- Target Recruit Count
- 48
- Registration Number
- NCT05788445
Study on the Prognostic Prediction Model of Patients With Acute Intracerebral Hemorrhage by Artificial Intelligence
Recruiting
- Conditions
- Cerebral HemorrhageArtificial IntelligencePrognosis
- First Posted Date
- 2022-06-21
- Last Posted Date
- 2022-06-21
- Lead Sponsor
- Beijing Neurosurgical Institute
- Target Recruit Count
- 150
- Registration Number
- NCT05424614
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
- Prev
- 1
- 2
- 3
- 4
- Next
News
No news found